Pierre Close

Pierre Close

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2018 in Nature
Verified
Journal Article
Closed access
PDF file
FRFrancesca Rapino
Francesca Rapino
SDSylvain Delaunay
Sylvain Delaunay
FRFlorian Rambow
Florian Rambow
ZZZhaoli Zhou
Zhaoli Zhou
LTLars Tharun
Lars Tharun
PCPierre Close
Pierre Close

10 October 2016 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SDSylvain Delaunay
Sylvain Delaunay
FRFrancesca Rapino
Francesca Rapino
LTLars Tharun
Lars Tharun
ZZZhaoli Zhou
Zhaoli Zhou
LHLukas C. Heukamp
Lukas C. Heukamp
PCPierre Close
Pierre Close
Quantitative and qualitative changes in mRNA translation occur in tumor cells and support cancer progression and metastasis. Posttranscriptional modifications of transfer RNAs (tRNAs) at the wobble uridine 34 (U34) base are highly conserved and contribute to translation fidelity. Here, we show that ELP3 and CTU1/2, partner enzymes in U34 mcm5s2-tRNA modification, are up-regulated in human breast cancers and sustain metastasis. Elp3 genetic ablation strongly impaired invasion and metastasis formation in the PyMT model of invasive breast cancer. Mechanistically, ELP3 and CTU1/2 support cellular invasion through the translation of the oncoprotein DEK. As a result, DEK promotes the IRES-dependent translation of the proinvasive transcription factor LEF1. Consistently, a DEK mutant, whose codon composition is independent of U34 mcm5s2-tRNA modification, escapes the ELP3- and CTU1-dependent regulation and restores the IRES-dependent LEF1 expression. Our results demonstrate that the key role of U34 tRNA modification is to support specific translation during breast cancer progression and highlight a functional link between tRNA modification– and IRES-dependent translation during tumor cell invasion and metastasis.

2 November 2015 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ALAurélie Ladang
Aurélie Ladang
FRFrancesca Rapino
Francesca Rapino
LHLukas C. Heukamp
Lukas C. Heukamp
LTLars Tharun
Lars Tharun
KSKateryna Shostak
Kateryna Shostak
ACAlain Chariot
Alain Chariot
Tumor initiation in the intestine can rapidly occur from Lgr5+ crypt columnar stem cells. Dclk1 is a marker of differentiated Tuft cells and, when coexpressed with Lgr5, also marks intestinal cancer stem cells. Here, we show that Elp3, the catalytic subunit of the Elongator complex, is required for Wnt-driven intestinal tumor initiation and radiation-induced regeneration by maintaining a subpool of Lgr5+/Dclk1+/Sox9+ cells. Elp3 deficiency dramatically delayed tumor appearance in Apc-mutated intestinal epithelia and greatly prolonged mice survival without affecting the normal epithelium. Specific ablation of Elp3 in Lgr5+ cells resulted in marked reduction of polyp formation upon Apc inactivation, in part due to a decreased number of Lgr5+/Dclk1+/Sox9+ cells. Mechanistically, Elp3 is induced by Wnt signaling and promotes Sox9 translation, which is needed to maintain the subpool of Lgr5+/Dclk1+ cancer stem cells. Consequently, Elp3 or Sox9 depletion led to similar defects in Dclk1+ cancer stem cells in ex vivo organoids. Finally, Elp3 deficiency strongly impaired radiation-induced intestinal regeneration, in part because of decreased Sox9 protein levels. Together, our data demonstrate the crucial role of Elp3 in maintaining a subpopulation of Lgr5-derived and Sox9-expressing cells needed to trigger Wnt-driven tumor initiation in the intestine.

23 June 2021 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
JJJana Jeschke
Jana Jeschke
ECEvelyne Collignon
Evelyne Collignon
CWClémence Al Wardi
Clémence Al Wardi
MKMohammad Krayem
Mohammad Krayem
MBMartin Bizet
Martin Bizet
FFFrançois Fuks
François Fuks

1 April 2017 in Trends in Cancer
Verified
Journal Article
Closed access
FRFrancesca Rapino
Francesca Rapino
SDSylvain Delaunay
Sylvain Delaunay
ZZZhaoli Zhou
Zhaoli Zhou
ACAlain Chariot
Alain Chariot
PCPierre Close
Pierre Close

1 September 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
PCPierre Close
Pierre Close
MGMagali Gillard
Magali Gillard
ALAurélie Ladang
Aurélie Ladang
ZJZheshen Jiang
Zheshen Jiang
JPJessica Papuga
Jessica Papuga
ACAlain Chariot
Alain Chariot
The Elongator complex is composed of 6 subunits (Elp1-Elp6) and promotes RNAPII transcript elongation through histone acetylation in the nucleus as well as tRNA modification in the cytoplasm. This acetyltransferase complex directly or indirectly regulates numerous biological processes ranging from exocytosis and resistance to heat shock in yeast to cell migration and neuronal differentiation in higher eukaryotes. The identity of human ELP1 through ELP4 has been reported but human ELP5 and ELP6 have remained uncharacterized. Here, we report that DERP6 (ELP5) and C3ORF75 (ELP6) encode these subunits of human Elongator. We further investigated the importance and function of these two subunits by a combination of biochemical analysis and cellular assays. Our results show that DERP6/ELP5 is required for the integrity of Elongator and directly connects ELP3 to ELP4. Importantly, the migration and tumorigenicity of melanoma-derived cells are significantly decreased upon Elongator depletion through ELP1 or ELP3. Strikingly, DERP6/ELP5 and C3ORF75/ELP6-depleted melanoma cells have similar defects, further supporting the idea that DERP6/ELP5 and C3ORF75/ELP6 are essential for Elongator function. Together, our data identify DERP6/ELP5 and C3ORF75/ELP6 as key players for migration, invasion and tumorigenicity of melanoma cells, as integral subunits of Elongator.